Krause I , Blumenfeld Z , Malchinsky M et al. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women . Lupus1998; 7: 377–382 .
2.
Jimena P , Aguirre MA , Lopez-Curbelo A , de Andres M , Garcia Courtay C , Cuadrado MJ . Prolactin levels in patients with systemic lupus erythematosus: a case controlled study . Lupus1998; 7: 383–386 .
3.
Miranda JM , Prieto RE , Paniagua R et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis . Lupus1998; 7: 387–391 .
4.
Ferreira C , Paes M , Gouveia A , Ferreira E , Padua F , Fiuza T . Plasma homovanillic acid and prolactin in systemic lupus erythematosus . Lupus1998; 7: 392–397 .
5.
Lanos A , Pascoe D , Fraga A , Blanco-Favela F . Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia . Lupus1998; 7: 398–403 .
6.
Gutierrez MA , Garcia ME , Rodriguez JA , Rivero S , Jacobelli S . Hypothalamic–pituitary–adrenal axis function and prolactin secretion in systemic lupus erythematosus . Lupus1998; 7: 404–408 .
7.
Rovensky J , Blazickova S , Rauova L et al. The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release . Lupus1998; 7: 409–413 .
8.
Alvarez-Nemegyei J , Cobarrubias-Cobos A , Escalante-Triay F et al. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study . Lupus1998; 7: 414–419 .
9.
Elbourne KB , Keisler D , McMurray RW . Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus . Lupus1998; 7: 420–427 .
